PM: decision on the application for modification of an agreed PIP
Decision date
Decision
P/0149/2023 : EMA decision of 21 April 2023 on the acceptance of a modification of an agreed paediatric investigation plan for anifrolumab (Saphnelo), (EMEA-001435-PIP02-16-M02)